Colombia may undergo historic change in Drug Policy

By Leandro Maia

In a shift in Colombian drug policy, President Gustavo Petro is exploring the feasibility of authorizing the production and commercialization of coca and poppy for medical, scientific, and industrial purposes. A draft decree released this Tuesday (19) outlines an ambitious proposal that could radically transform the current scenario.

The document in question seeks to regulate crucial aspects, from the authorization and possession of seeds to cultivation licenses and the use of unlicensed plantations exclusively for specific purposes, moving away from the stigma historically associated with these plants due to their role in drug trafficking, violence, and armed conflict.

Read also:
CBD in the treatment against insomnia and acne

Check out the schedule of the Brazilian Medicinal Cannabis Congress

President Petro, in his attempt to promote the transition from illicit to licit economies and dismantle criminal organizations dedicated to drug trafficking, announced an ongoing investigation. This seeks to identify the properties, potentialities, and purposes of poppy, cannabis, and coca plants, offering a more holistic and future-oriented approach.

Colombia, for decades one of the world's largest coca producers, faces an internal armed conflict fueled by cocaine for almost six decades. Petro's proposal, however, is not without criticism. Opposition lawmakers, such as Senator David Luna of the Radical Change party, have raised concerns on social media, arguing that the proposed decree would directly violate the Constitution and could inadvertently legalize criminal structures involved in drug trafficking.

Currently, Colombian legislation allows for the harvesting and possession of limited quantities for personal use, as well as the production and export of medicinal cannabis. However, the complexity of the regulation has been an obstacle to the growth of this industry in the country.

Petro's proposal signals a significant change in the country's approach to the use of these plants, aiming not only to break the drug production but also to transition to lawful activities. The process, however, will face considerable challenges, reflecting the divergences within the Colombian political landscape. The fate of this innovative proposal remains uncertain as the country closely watches the developments that may shape its future in drug policy.